We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$6.42B
Cap. Flow
-$9.95B
Cap. Flow %
-14.55%
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$433M
2
MRK icon
Merck
MRK
+$286M
3
J icon
Jacobs Solutions
J
+$265M
4
EFX icon
Equifax
EFX
+$253M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$240M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$710M
2
JNJ icon
Johnson & Johnson
JNJ
+$574M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M
4
MRVL icon
Marvell Technology
MRVL
+$377M
5
WFC icon
Wells Fargo
WFC
+$333M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 14.64%
3 Healthcare 12%
4 Industrials 10.54%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAIA icon
2326
Saia
SAIA
$9.64B
– –
-77
Closed -$33K
SANA icon
2327
Sana Biotechnology
SANA
$968M
$0 ﹤0.01%
132
– –
ECHO
2328
EchoStar
ECHO
$25.5B
$0 ﹤0.01%
40
-2,710
-99% -$65.6K
SBET icon
2329
Sharplink Inc
SBET
$1.34B
$0 ﹤0.01%
+85
New +$731
SBGI icon
2330
Sinclair Inc
SBGI
$1.01B
$0 ﹤0.01%
47
-23,523
-100% -$396K
SCL icon
2331
Stepan Co
SCL
$1.45B
– –
-321
Closed -$24K
SCOR icon
2332
Comscore
SCOR
$115M
$0 ﹤0.01%
+112
New +$749
SCYX icon
2333
SCYNEXIS
SCYX
$51.7M
– –
-138
Closed -$1K
SGHT icon
2334
Sight Sciences
SGHT
$303M
– –
-1,394
Closed -$8K
SGRP
2335
DELISTED
SPAR Group
SGRP
– –
-1,320
Closed -$3K
SHIP icon
2336
Seanergy Maritime Holdings
SHIP
$365M
– –
-1,131
Closed -$14K
SILO icon
2337
Silo Pharma
SILO
$5.21M
$0 ﹤0.01%
64
-4
-6% -$62
SLDB icon
2338
Solid Biosciences
SLDB
$853M
$0 ﹤0.01%
81
– –
SLRC icon
2339
SLR Investment Corp
SLRC
$688M
– –
-21,219
Closed -$319K
SMG icon
2340
ScottsMiracle-Gro
SMG
$3.87B
– –
-399
Closed -$34K
SMTI icon
2341
Sanara MedTech
SMTI
$313M
$0 ﹤0.01%
6
-7,595
-100% -$258K
SNCR
2342
DELISTED
Synchronoss Technologies
SNCR
$0 ﹤0.01%
86
-28
-25% -$297
SPFI icon
2343
South Plains Financial
SPFI
$853M
– –
-41
Closed -$1K
SPXC icon
2344
SPX Corp
SPXC
$10.8B
– –
-1,629
Closed -$259K
SSP icon
2345
E.W. Scripps
SSP
$263M
$0 ﹤0.01%
+376
New +$868
STKS icon
2346
The ONE Group
STKS
$55.9M
$0 ﹤0.01%
252
-4,252
-94% -$14.1K
STOK icon
2347
Stoke Therapeutics
STOK
$1.98B
$0 ﹤0.01%
58
– –
STRO icon
2348
Sutro Biopharma
STRO
$419M
– –
-963
Closed -$33K
SWIM icon
2349
Latham Group
SWIM
$845M
– –
-10,818
Closed -$73K
SYNA icon
2350
Synaptics
SYNA
$3.97B
– –
-868
Closed -$66K
92 93
94
95 96

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lazard Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.

  • Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
  • Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
  • Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
  • Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
  • Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
  • Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.